65,437 trials
Asthma · Cockroach Hypersensitivity
Primary: Cumulative Proportion of Participants Meeting Either a Total Nasal Symptom Score (TNSS) Threshold or Sneezing Score Threshold During the Cockroach Allergen (CA) Nasal…
Prostate Cancer
Primary: PET Detection of Primary Prostate Cancer — 6; 7 Participants
Mental Health · Neurology · Health Services
Primary: PHQ-9 — 6.4; 4.4 units on a scale
Liver Transplantation · Kidney Transplantation
Primary: Delayed Kidney Graft Function — 5; 7 Participants
Intestinal Cancer · Diverticulitis · Pancreatic Cancer
Primary: Bioimpedance Assessment — 0.53 ohms
Leukemia
Primary: Overall Response Rate (ORR) of IMGN901 in Participants CD56 Expressing Hematological Malignancies — 0; 0; 0 Participants
Asthma
Primary: Baseline Pre-dose Forced Expiratory Volume in One Second (FEV1) — 2.264; 2.234 Liter
Cancer · Anxiety
Primary: Change in Anxiety Symptoms From Baseline to Post-assessment — -2.99; -1.85 Units on a scale — p=0.412
Hereditary Angioedema (HAE)
Primary: Normalized Number of Angioedema Attacks Per Month in a Treatment Period — 1.2; 0.7 Angioedema attacks per month — p=0.03
Dental Caries · Restorative Material
Primary: Percent of Teeth With Anatomic Form Graded as A or B. — 42; 37; 40; 2 teeth — p=0.2552
Leukemia
Primary: Number of Patients Showing a Reduction by at Least 50% of Peripheral Blood BCR-ABL/ABL Ratio Compared to the Individual Prevaccine Level — 22; 14 participants
Pre Diabetes · Obesity · Metabolic Syndrome
Primary: Hemoglobin A1c — 5.9; 5.8; 5.9; 5.9 percent HbA1c
Endometrial Carcinoma · Recurrent Uterine Corpus Carcinoma · Stage IIIA Uterine Corpus Cancer
Primary: Percentage of Participants With a Confirmed Objective Tumor Response Using RECIST Version 1.0 — 22; 14.3 percentage of participants
Type 2 Diabetes Mellitus
Primary: Forearm Blood Flow — 1.72; 2.29; 1.17; 1.63 mL/min/100 mL
Biceps Tendonitis
Primary: Post-operative Axillary Pain — 3; 0 units on a scale